The Journey to Deprescribing Isn’t Always a Smooth Road

“This is important to me and to many geriatricians: the point of deprescribing is that we can do something,” said Daniel Haimowitz, MD, FACP, CMD, who spoke on this topic at the live AMDA On-The-Go podcast at the annual conference of AMDA — The Society for Post-Acute and Long-Term Care Medicine. He noted that when people fall prey to polypharmacy in the community, “we can do good things for them when they come to our care. We can improve their quality of life.”